Skip to content

Released May 9, 2024, after the close

10-Q filed May 10, 2024, 40 days after period end · 0001636422-24-000075

Q1 2024 · 10-Q
Revenue$74.72M+1.2% vs Q1 2023−0.5% vs Q4 2023
Net Income-$20.59MN/M vs Q1 2023N/M vs Q4 2023
EPS Diluted-$0.35N/M vs Q1 2023no prior Q4 2023 on file
Operating Income-$22,812,000N/M
Operating Cash Flow$10,266,000N/M
Free Cash Flowderived$10,058,000N/M
Margins · derived
Operating margin-30.5%+16.7 pt vs Q1 2023
Net margin-27.6%+17.4 pt vs Q1 2023

What the release said

The release

Same quarter

MetricQ1 2024Q1 2023Q1 2022Q1 2021
Revenue$74.72M$73.87M$68.09M$55.85M
Net Income-$20.59M-$33.19M-$22.46M-$28.37M
EPS Diluted-$0.35-$0.60-$0.54-$0.65

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR